當(dāng)前位置：   首頁(yè) > 需求大廳

說(shuō)明書(shū)一份   [更多]

1.Title：Studies of the polymorphism of sodium valproate. (Ger.). Authors：Kleinebudde P; Thies R Publication Name：Sci.Pharm. Publication Year：1999 Keywords：Valproate Sodium/Oc Crystal/Ft Polymorphism/Ft Calorimetry/Ft X-Ray- Diffraction/Ft Analysis/Ft Crystallography/Ft Anticonvulsants/Ft Antimanics / Ft Oc / Ft Extract：2 Crystal modifications (M1 and M2) of Na valproate (NV) have been detected at RT, while a further form (M3) occurred at temperatures above 100 deg. Untreated NV, which had been recrystallized from toluene or ethyl acetate occurred as modification M1. These modifications were examined by thermoanalytical (DSC, thermogravimetry) and X-ray crystallographic methods. 2.【題名】Polymorphism of sodium valproate 【作 者】Mifsud, H.;Miguel, L.;Lavastre, V.;Maire, G. 【刊 名】Calorim. Anal. Therm. Calorimetrie et Analyse Thermique 【出版日期】1993 【卷 號(hào)】Vol.24 【頁(yè) 碼】309-312 【關(guān)鍵詞】polymorphism sodium valproate Polymorphism of sodium valproate 1069-66-5 polymorphism 【摘 要】Polymorphism anal. is of fundamental pharmaceutical importance for correct development of a drug, as it provides valuable knowledge of its biopharmaceutical and technol. aspects. Indeed, different polymorphs exhibit different phys. properties that can affect bioavailability. Polymorphism screening has been developed in the authors' lab., based on crystn. parameter variations for a given drug in soln. Sodium valproate is an anti-epileptic drug commercialized under the name Depakine. Five polymorphic forms were obtained by the screening and characterized by differential scanning calorimetry, X-ray powder diffractometry, thermogravimetry and IR spectroscopy. The relationships between these forms were examd.   [更多]

求助硫辛酸注射液進(jìn)口注冊(cè)質(zhì)量信息，要求沒(méi)有公司印章。   [更多]

求購(gòu)左氧氟沙星片標(biāo)準(zhǔn)   [更多]

復(fù)方聚乙二醇電解質(zhì)散（IV）舒泰清的質(zhì)量標(biāo)準(zhǔn)   [更多]

標(biāo)準(zhǔn)來(lái)源： 進(jìn)口藥品復(fù)核標(biāo)準(zhǔn)匯編2002年吸入用復(fù)方異丙托溴銨溶液　【注冊(cè)證號(hào)】 H20020433（第763頁(yè)）【英 文 名】 Compound Ipratropium Bromide Solution for Inhalation【生產(chǎn)廠商】 英國(guó)　Boehringer Ingelheim Limited【標(biāo) 準(zhǔn) 號(hào)】 JX19990360已有新版JX20100077標(biāo)準(zhǔn)，但是沒(méi)有雜質(zhì)結(jié)構(gòu)式信息，尋找老版標(biāo)準(zhǔn)是否有雜質(zhì)結(jié)構(gòu)式，要求有雜質(zhì)BA686BR、BIRT0109BR、BIRJ0416BR、BIRJ0420BR結(jié)構(gòu)式，如果沒(méi)有的話，還是就不能認(rèn)定有效哦！   [更多]

①?gòu)娜蝿?wù)主手中獲取指定年份的分析報(bào)告（PDF）②分析報(bào)告中的內(nèi)容要是2019年和2018年的藥品流通行業(yè)運(yùn)行統(tǒng)計(jì)分析③要求仔細(xì)認(rèn)真，有責(zé)任心④以前合作做過(guò)類似項(xiàng)目的優(yōu)先考慮，如有感興趣的威客可聯(lián)系參與   [更多]

急需冷敷凝膠、冷敷凝膠膏體及冷敷乳的一類醫(yī)療器械全套備案申請(qǐng)資料   [更多]

需要?dú)庀嘁合嗌V中出現(xiàn)異常峰的管理制度。包含了清晰驗(yàn)證中的異常峰管理、殘留溶劑的異常峰管理（基因毒）等。   [更多]

求購(gòu)最新他氟前列素滴眼液進(jìn)口藥品注冊(cè)標(biāo)準(zhǔn)JX2018，清晰電子版   [更多]